{"title":"13价肺炎球菌结合疫苗接种前后hiv感染儿童肺炎链球菌的鼻咽携带及血清型分布","authors":"Wisiva Tofriska Paramaiswari, Dina Muktiarti, Dodi Safari, Rizqi Amalia, Melati Padma, Yayah Winarti, Miftahuddin Majid Khoeri, Wa Ode Dwi Daningrat, Wisnu Tafroji, Amin Soebandrio","doi":"10.7774/cevr.2025.14.e19","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The objective of this study was to determine the prevalence of colonization, serotype distribution, and antimicrobial susceptibility profile of <i>Streptococcus pneumoniae</i> (Pneumococcus) isolated from human immunodeficiency virus (HIV)-infected children before and after single-dose of 13-valent pneumococcal conjugate vaccine (PCV13) vaccination.</p><p><strong>Materials and methods: </strong>We conducted a prospective cohort study among HIV-infected children above six years of age in Jakarta, Indonesia. Nasopharyngeal swabs were collected from 50 children before vaccination, 12 months, and 18 months after PCV13 vaccination. The swabs were evaluated by bacterial culture, and serotyping were performed using sequential multiplex polymerase chain reactions and Quellung reactions. Antimicrobial susceptibility profiles were determined using the disk diffusion method.</p><p><strong>Results: </strong>We found <i>Streptococcus pneumoniae</i> colonized 46% (23/50) of total children enrolled before vaccination, which decreased to 19% (n=9/47) at 12 months post-vaccination and 29% (14/48) at 18 months post-vaccination. There was no significant difference in the prevalence of pneumococcal colonization between vaccinated and unvaccinated HIV-infected children (p>0.05). There was a significant decrease in pneumococcal colonization between the baseline, 12 months, and 18 months after vaccination among vaccinated children (p<0.05). Vaccine-type (VT) serotypes (6B, 23F, and 19A) were more prevalent than non-vaccine serotypes before vaccination. Non-vaccine type (NVT) serotypes (6C, 15C) were more prevalent at 12 months post-vaccination. VT serotypes were found at 18 months post-vaccination in vaccinated children. There was a high prevalence of antimicrobial resistance to <i>S. pneumoniae</i> isolates to oxacillin, tetracycline, and sulfamethoxazole-trimethoprim before and after vaccination.</p><p><strong>Conclusion: </strong>There was a decrease in pneumococcal carriage after PCV vaccination in HIV-infected children, accompanied by changes in serotype distribution from VT serotypes to NVT serotypes.</p>","PeriodicalId":51768,"journal":{"name":"Clinical and Experimental Vaccine Research","volume":"14 2","pages":"127-137"},"PeriodicalIF":2.1000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12046085/pdf/","citationCount":"0","resultStr":"{\"title\":\"Nasopharyngeal carriage and serotype distribution of <i>Streptococcus pneumoniae</i> among HIV-infected children aged >6 years: before and after vaccination of 13-valent pneumococcal conjugate vaccine.\",\"authors\":\"Wisiva Tofriska Paramaiswari, Dina Muktiarti, Dodi Safari, Rizqi Amalia, Melati Padma, Yayah Winarti, Miftahuddin Majid Khoeri, Wa Ode Dwi Daningrat, Wisnu Tafroji, Amin Soebandrio\",\"doi\":\"10.7774/cevr.2025.14.e19\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>The objective of this study was to determine the prevalence of colonization, serotype distribution, and antimicrobial susceptibility profile of <i>Streptococcus pneumoniae</i> (Pneumococcus) isolated from human immunodeficiency virus (HIV)-infected children before and after single-dose of 13-valent pneumococcal conjugate vaccine (PCV13) vaccination.</p><p><strong>Materials and methods: </strong>We conducted a prospective cohort study among HIV-infected children above six years of age in Jakarta, Indonesia. Nasopharyngeal swabs were collected from 50 children before vaccination, 12 months, and 18 months after PCV13 vaccination. The swabs were evaluated by bacterial culture, and serotyping were performed using sequential multiplex polymerase chain reactions and Quellung reactions. Antimicrobial susceptibility profiles were determined using the disk diffusion method.</p><p><strong>Results: </strong>We found <i>Streptococcus pneumoniae</i> colonized 46% (23/50) of total children enrolled before vaccination, which decreased to 19% (n=9/47) at 12 months post-vaccination and 29% (14/48) at 18 months post-vaccination. There was no significant difference in the prevalence of pneumococcal colonization between vaccinated and unvaccinated HIV-infected children (p>0.05). There was a significant decrease in pneumococcal colonization between the baseline, 12 months, and 18 months after vaccination among vaccinated children (p<0.05). Vaccine-type (VT) serotypes (6B, 23F, and 19A) were more prevalent than non-vaccine serotypes before vaccination. Non-vaccine type (NVT) serotypes (6C, 15C) were more prevalent at 12 months post-vaccination. VT serotypes were found at 18 months post-vaccination in vaccinated children. There was a high prevalence of antimicrobial resistance to <i>S. pneumoniae</i> isolates to oxacillin, tetracycline, and sulfamethoxazole-trimethoprim before and after vaccination.</p><p><strong>Conclusion: </strong>There was a decrease in pneumococcal carriage after PCV vaccination in HIV-infected children, accompanied by changes in serotype distribution from VT serotypes to NVT serotypes.</p>\",\"PeriodicalId\":51768,\"journal\":{\"name\":\"Clinical and Experimental Vaccine Research\",\"volume\":\"14 2\",\"pages\":\"127-137\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12046085/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical and Experimental Vaccine Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.7774/cevr.2025.14.e19\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/3/31 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Vaccine Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7774/cevr.2025.14.e19","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/31 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
Nasopharyngeal carriage and serotype distribution of Streptococcus pneumoniae among HIV-infected children aged >6 years: before and after vaccination of 13-valent pneumococcal conjugate vaccine.
Purpose: The objective of this study was to determine the prevalence of colonization, serotype distribution, and antimicrobial susceptibility profile of Streptococcus pneumoniae (Pneumococcus) isolated from human immunodeficiency virus (HIV)-infected children before and after single-dose of 13-valent pneumococcal conjugate vaccine (PCV13) vaccination.
Materials and methods: We conducted a prospective cohort study among HIV-infected children above six years of age in Jakarta, Indonesia. Nasopharyngeal swabs were collected from 50 children before vaccination, 12 months, and 18 months after PCV13 vaccination. The swabs were evaluated by bacterial culture, and serotyping were performed using sequential multiplex polymerase chain reactions and Quellung reactions. Antimicrobial susceptibility profiles were determined using the disk diffusion method.
Results: We found Streptococcus pneumoniae colonized 46% (23/50) of total children enrolled before vaccination, which decreased to 19% (n=9/47) at 12 months post-vaccination and 29% (14/48) at 18 months post-vaccination. There was no significant difference in the prevalence of pneumococcal colonization between vaccinated and unvaccinated HIV-infected children (p>0.05). There was a significant decrease in pneumococcal colonization between the baseline, 12 months, and 18 months after vaccination among vaccinated children (p<0.05). Vaccine-type (VT) serotypes (6B, 23F, and 19A) were more prevalent than non-vaccine serotypes before vaccination. Non-vaccine type (NVT) serotypes (6C, 15C) were more prevalent at 12 months post-vaccination. VT serotypes were found at 18 months post-vaccination in vaccinated children. There was a high prevalence of antimicrobial resistance to S. pneumoniae isolates to oxacillin, tetracycline, and sulfamethoxazole-trimethoprim before and after vaccination.
Conclusion: There was a decrease in pneumococcal carriage after PCV vaccination in HIV-infected children, accompanied by changes in serotype distribution from VT serotypes to NVT serotypes.
期刊介绍:
Clin Exp Vaccine Res, the official English journal of the Korean Vaccine Society, is an international, peer reviewed, and open-access journal. It covers all areas related to vaccines and vaccination. Clin Exp Vaccine Res publishes editorials, review articles, special articles, original articles, case reports, brief communications, and correspondences covering a wide range of clinical and experimental subjects including vaccines and vaccination for human and animals against infectious diseases caused by viruses, bacteria, parasites and tumor. The scope of the journal is to disseminate information that may contribute to elaborate vaccine development and vaccination strategies targeting infectious diseases and tumors in human and animals. Relevant topics range from experimental approaches to (pre)clinical trials for the vaccine research based on, but not limited to, basic laboratory, translational, and (pre)clinical investigations, epidemiology of infectious diseases and progression of all aspects in the health related issues. It is published printed and open accessed online issues (https://ecevr.org) two times per year in 31 January and 31 July. Clin Exp Vaccine Res is linked to many international databases and is made freely available to institutions and individuals worldwide